Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Knowledge of the regulation of testicular retinoic acid synthesis is crucial for understanding its role in spermatogenesis. Bisdichloroacetyldiamines strongly inhibit spermatogenesis. We reported previously that one of these compounds,
WIN 18,446
, potently inhibited spermatogenesis in rabbits by inhibiting retinoic acid synthesis. To understand how
WIN 18,446
inhibits retinoic acid synthesis, we characterized its effects on human retinal dehydrogenase ALDH1A2 in vitro as well as its effects on retinoid metabolism in vivo using mice.
WIN 18,446
strongly and irreversibly inhibited ALDH1A2 in vitro. In vivo,
WIN 18,446
treatment completely abolished spermatogenesis after 4 weeks of treatment and modestly reduced adiposity in mice fed a chow diet. Effects of
WIN 18,446
on retinoid concentrations were tissue-dependent. Although lung and liver retinyl ester concentrations were lower in
WIN 18,446
-treated animals, adipose retinyl ester levels were increased following the treatment. Interestingly, animals treated with
WIN 18,446
had significantly higher circulating retinol concentrations compared with control mice. The effect on spermatogenesis by
WIN 18,446
was not prevented by simultaneous treatment with retinoic acid, whereas effects on other tissues were partially or completely reversed. Cessation of
WIN 18,446
treatment for 4 weeks reversed most retinoid-related phenotypes except for inhibition of spermatogenesis. Our data suggest that
WIN 18,446
may be a useful model of systemic acquired retinoic acid deficiency. Given the effects observed in our study, inhibition of retinoic acid biosynthesis may have relevance for the treatment of
obesity
and in the development of novel male contraceptives.
...
PMID:Inhibition of retinoic acid biosynthesis by the bisdichloroacetyldiamine WIN 18,446 markedly suppresses spermatogenesis and alters retinoid metabolism in mice. 2471 51